The mechanism of immune insufficiency against retroviral tumors and its restoration
The mechanism of immune insufficiency against retroviral tumors and its restoration
批准号:
15023217
负责人:
KANNAGI Mari
金额:
$10.94万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
It has been noted that adult T-cell leukemia (ATL) is incidentally associated with mother-to-child infection, mostly established via mother milk. In our rat system, orally infected rats exhibited significantly higher levels of persistent human T-cell leukemia virus type I (HTLV-I) load and much weaker immune response to HTLV-I than that in intraperitoneally infected rats. As a result, persistent viral load was inversely correlated with levels of virus-specific T-cell responses. The insufficient immune responses in orally infected rats could be, however, recovered by subcutaneous re-immunization with appropriate antigens. We also investigated cellular immune responses of ATL patients who obtained complete remission following non-myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling donors, and found that HTLV-I Tax-specific CTL response was strongly activated in some of these patients post-HSCT but not before HSCT. These findings suggest that HTLV-I-specific immune insufficiency established at primary HTLV-I infection may be an underlying risk factor for development of ATL, but could be overcome with immunological strategies.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
H.Liu, T.Ohashi, T.Masuda.X.Zhou, M.Kubo, M.Kannagi: "Suppression of HIV-I replication by HIV-I-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-I-infected cells in vitro."Viral Immunology. 16. 381-393 (2003)
H.Liu、T.Ohashi、T.Masuda.X.Zhou、M.Kubo、M.Kannagi:“通过与 HIV-1 无关的 CD8 细胞毒性 T 淋巴细胞抑制 HIV-1 复制,导致持续保存 HIV-1-
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1002/ijc.20737
发表时间:
2005-03-20
期刊:
INTERNATIONAL JOURNAL OF CANCER
影响因子:
6.4
作者:
[Kurihara, K, Harashima, N, Kannagi, M]
通讯作者:
Kannagi, M
Future prophylaxis and immunotherapy for adult T cell leukemia.
成人 T 细胞白血病的未来预防和免疫治疗。
DOI:
--
发表时间:
2004
期刊:
Expert Review of Anticancer Therapy 4
影响因子:
--
作者:
[M.Kannagi, et al.]
通讯作者:
et al.
Correlation of major hi stocompatibi1ity complex class I downregulation with resistance of human T cell leukemia virus type I-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
在大鼠模型中,主要组织相容性复合体 I 类下调与人 T 细胞白血病病毒 I 型感染的 T 细胞对细胞毒性 T 淋巴细胞杀伤的抵抗力的相关性。
DOI:
--
发表时间:
2002
期刊:
J.Virol. 76
影响因子:
--
作者:
[T.Ohashi, S.Hanabuchi, R.Suzuki, H.Kato, H.Tateno, T.Masuda, M.Kannagi.]
通讯作者:
M.Kannagi.
Correlation of major histocompatibility complex class I downregulation with resistance of human T cell leukemia virus type I-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
在大鼠模型中,主要组织相容性复合物 I 类下调与人 T 细胞白血病病毒 I 型感染的 T 细胞对细胞毒性 T 淋巴细胞杀伤的抵抗力的相关性。
DOI:
--
发表时间:
2002
期刊:
J.Virol. 76
影响因子:
--
作者:
[T.Ohashi, et al.]
通讯作者:
et al.
共 15 条
Host innate immune mechanisms separating inflammatory or lymphoproliferative diseases in HTLV-1 infection
-
批准号:20K07512
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2020
-
负责人:KANNAGI Mari
-
依托单位:
Anti-viral immuno therapeutic approaches for adult T-cell leukemia
-
批准号:17013028
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$31.04万
-
财政年份:2005
-
负责人:KANNAGI Mari
-
依托单位:
Role of vertical transmission of HTLV-I on the risk for T cell malignancy
-
批准号:12470052
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.91万
-
财政年份:2000
-
负责人:KANNAGI Mari
-
依托单位:
Spontaneous inhibition of HTL V-I expression in the peripheral blood
-
批准号:06670333
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.58万
-
财政年份:1994
-
负责人:KANNAGI Mari
-
依托单位:
Characterization of the HTLV-I receptor
-
批准号:04670276
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.32万
-
财政年份:1992
-
负责人:KANNAGI Mari
-
依托单位:
海外基金